Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Ther Adv Neurol Disord. 2010 Jan;3(1):43-52. doi: 10.1177/1756285609349521.

Progress in the management of paraneoplastic neurological disorders.

Author information

  • 1Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Abstract

Paraneoplastic neurological disorders (PNDs) are a rare and diverse group of neurological conditions that can involve any part of the nervous system. Diagnosis is facilitated by finding well-recognized autoantibodies directed against neural antigens in the sera and the cerebrospinal fluid. Identifying and eliminating the underlying malignancy is the mainstay of treatment. Immunomodulatory treatment is gaining more acceptance especially, where a malignancy could not be identified, oncology treatment is completed, or along with cancer treatment. Literature review shows only a handful of systematic prospective case series. Multicenter, prospective controlled clinical trials are needed for future therapeutic advances.

KEYWORDS:

cyclophosphamide; intravenous immunoglobulin; limbic encephalitis; neuroimmunology; plasma exchange

PMID:
21180635
[PubMed]
PMCID:
PMC3002612
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Write to the Help Desk